Bone building drugs show some hopes as a wider anti-cancer drugs

CHICAGO—There is a possible new way to fight against breast cancer as doctors are quite excited to find that a drug which is used to avoid bone loss during breast cancer cure may significantly lower the risk of reoccurrence of breast cancer.
Zometa and other bone-building drugs known as bisphosphonates show some hope as a wider anti-cancer drugs in this first large study. The cancers that already spread to the bone are treated by Zometa, a drug developed by Novartis AG.

1,800 premenopausal women who were getting hormone treatments for their initial stage breast cancer included in this new study. It was found that Zometa reduced almost one-third chances that the cancer would return. …Click here to read more